Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Moccia

Showing results (121-130 of 221) with videos related to

Pageof 23
Sort By:
Journal of Neurology|May 22, 2024
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosisIsabel Monteiro, Valerio Nicolella, Mariano Fiorenza, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 11, 2021
B Cells in the CNS at Postmortem Are Associated With Worse Outcome and Cell Types in Multiple SclerosisMarcello Moccia, Lukas Haider, Arman Eshaghi, et al.
Journal of Clinical Medicine|December 24, 2021
Retinal and Choriocapillary Vascular Changes in Early Stages of Multiple Sclerosis: A Prospective StudyDaniela Montorio, Roberta Lanzillo, Antonio Carotenuto, et al.
Frontiers in Neurology|October 17, 2024
Technological interventions in European dementia care: a systematic review of acceptance and attitudes among people living with dementia, caregivers, and healthcare workersMichele Sorrentino, Claudio Fiorilla, Michelangelo Mercogliano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2018
e-Health and multiple sclerosis: An updateLuigi Lavorgna, Francesco Brigo, Marcello Moccia, et al.
Journal of Neuroimmunology|June 12, 2017
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patientsAntonio Carotenuto, Giulia Scalia, Francesco Ausiello, et al.
Therapeutic Advances in Neurological Disorders|March 1, 2019
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosisMarcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.
Neurology International|April 26, 2024
Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based StudyMarcello Moccia, Giuseppina Affinito, Giuseppina Marrazzo, et al.
Multiple Sclerosis and Related Disorders|July 1, 2023
Exploring the relation between reserve and fatigue in multiple sclerosisMario Tranfa, Valentina Virginia Iuzzolino, Pierpaolo Perrella, et al.
International Journal of Molecular Sciences|December 11, 2022
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of LiteratureAntonio Luca Spiezia, Antonio Carotenuto, Aniello Iovino, et al.
Pageof 23

Showing results (121-130 of 221) with videos related to

Sort By:
Pageof 23
Journal of Neurology|May 22, 2024
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosisIsabel Monteiro, Valerio Nicolella, Mariano Fiorenza, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 11, 2021
B Cells in the CNS at Postmortem Are Associated With Worse Outcome and Cell Types in Multiple SclerosisMarcello Moccia, Lukas Haider, Arman Eshaghi, et al.
Journal of Clinical Medicine|December 24, 2021
Retinal and Choriocapillary Vascular Changes in Early Stages of Multiple Sclerosis: A Prospective StudyDaniela Montorio, Roberta Lanzillo, Antonio Carotenuto, et al.
Frontiers in Neurology|October 17, 2024
Technological interventions in European dementia care: a systematic review of acceptance and attitudes among people living with dementia, caregivers, and healthcare workersMichele Sorrentino, Claudio Fiorilla, Michelangelo Mercogliano, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2018
e-Health and multiple sclerosis: An updateLuigi Lavorgna, Francesco Brigo, Marcello Moccia, et al.
Journal of Neuroimmunology|June 12, 2017
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patientsAntonio Carotenuto, Giulia Scalia, Francesco Ausiello, et al.
Therapeutic Advances in Neurological Disorders|March 1, 2019
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosisMarcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.
Neurology International|April 26, 2024
Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based StudyMarcello Moccia, Giuseppina Affinito, Giuseppina Marrazzo, et al.
Multiple Sclerosis and Related Disorders|July 1, 2023
Exploring the relation between reserve and fatigue in multiple sclerosisMario Tranfa, Valentina Virginia Iuzzolino, Pierpaolo Perrella, et al.
International Journal of Molecular Sciences|December 11, 2022
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of LiteratureAntonio Luca Spiezia, Antonio Carotenuto, Aniello Iovino, et al.
Pageof 23